Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 

Immunitor at 3rd Virtual HIV/AIDS Congress


Immunitor at 3rd Virtual HIV/AIDS Congress to commemorate AIDS day

Immunitor Company announces presentation of a paper ‘Mucosal AIDS vaccines’ at the 3rd Virtual HIV/AIDS Congress which started on internet on October 14, 2002 and closed on World AIDS day on December 1, 2002.

The complete html or PDF version of the paper can be found at http://www.aidscongress.net/article.php?id_comunicacao=143.

The paper is presented in Basic Science section. Other topics covered at this Congress include: Social and Behavioral Science; Epidemiology, Prevention and Public Health; Clinical Science and Care; and HIV and Tuberculosis. This Congress is the third annual event organized by AIDSPortugal.com - the non-profit Portuguese association SIDAnet which unites medical professionals and social workers to provide treatment and counseling for people with AIDS.

The presented paper summarizes as to what is the best strategy for developing a potent AIDS vaccine since all feasible and obvious approaches in making AIDS vaccines have been tried in past two decades without much of success. The presentation draws attention to the fact that new thinking and revision of prevailing dogmas needs to be in place if we really want a vaccine. Conventional envelope-based antibody-inducing vaccines do not appear to hold a promise and cellular immune responses, especially those mediated by CD8 cytotoxic/suppressor (CTL) and CD4 helper T lymphocytes, seem to be needed to control HIV. Vaccines capable of inducing cell-mediated responses are, therefore, considered critical for controlling the spread of HIV. DNA-based vaccines are currently thought to be an answer but will they fulfill the promise? The review of state-of-the-art is provided to summarize what we know and still don’t know. The focus of the discussion is primarily on mucosal vaccines – relatively new area in AIDS research. The update on V-1 Immunitor, the oral AIDS vaccine produced in Thailand, is provided within this context. The paper ended with a conclusion that without departure from the uninspiring consensus no substantial progress in AIDS vaccine field can be envisioned.


© Scoop Media

 
 
 
Business Headlines | Sci-Tech Headlines

 

Hospitality NZ: Hospitality Wages Jump 9% To Pass Living Wage
Wages and salaries across the hospitality sector continue to increase despite businesses having to battle through some of the toughest trading periods in living memory... More>>



Climate Leaders Coalition: Launches New Statement Of Ambition, Appoints New CEO Convenor

The Climate Leaders Coalition is tonight officially launching a new Statement of Ambition to accelerate business action on climate change... More>>


Retail: New Law Paves Way For Greater Supermarket Competition

Legislation that bans major supermarkets from blocking their competitors’ access to land to set up new stores paves the way for greater competition in the sector, Minister of Commerce and Consumer Affairs Dr David Clark said... More>>



MYOB: New Data Shows Increase In SMEs Experiencing Stress And Anxiety

The lingering impacts of the COVID-19 pandemic have led to a surge in the number of local SME owners and operators experiencing stress and anxiety, according to new research from business management platform, MYOB... More>>



Carbonz: Cashing In On Carbon: The New Marketplace Helping Native Forest To Thrive

The country’s first voluntary carbon credit marketplace, Carbonz, is here to restore native biodiversity and help Aotearoa reach its carbon zero goals by selling the first carbon credits exclusively from native forest... More>>
Entrust District: Dividend Will Be Welcomed After Another Tough Year
We’ve all heard of the saying; “if it sounds too good to be true, it probably is” but for Aucklanders within the Entrust District, getting their share of Entrust’s 2022 annual dividend payment really is as good as it sounds... More>>